PACAP is hét platform voor lange termijn onderzoek

naar de behandeling en (patiënt gerapporteerde)
uitkomsten van alvleesklierkanker

48

deelnemende
centra

1925

patiënten in
PACAP PROMs

2913

patiënten in
PACAP cohort

There is often an overlap in both questionnaires and patient population in PACAP PROMs and other projects. By collaborating, we avoid that patients fill in questionnaires twice. PACAP collaborates with the following studies.

DIPLOMA

15 maart 2021

Distal pancreatectomy, minimally invasive or open, for malignancy: a Pan-European randomized multicenter study

Read more

PANFIRE-III

18 maart 2021

Study investigating treatment with IRE (nanoknife) of the primary tumor whether or not in combination with immunotherapy in inoperable pancreatic patients with liver metastases

Read more

PEGASUS

14 maart 2021

Study investigating treatment with IRE (nanoknife) of the primary tumor whether or not in combination with immunotherapy in inoperable pancreatic patients with liver metastases

Read more

PREOPANC-2

13 maart 2021

Neoadjuvant FOLFIRINOX versus neoadjuvant chemoradiotherapy and adjuvant chemotherapy for (borderline) resectable pancreatic carcinoma

Read more

eQuiPe

12 maart 2021

How do patients with advanced cancer and their loved ones experience quality of life and quality of care

Read more